Advertisement

Topics

Prostate Cancer Foundation of Chicago Company Profile

01:12 EDT 21st September 2017 | BioPortfolio


News Articles [7031 Associated News Articles listed on BioPortfolio]

Elena Castro receives a Young Investigator Award from the Prostate Cancer Foundation

(Centro Nacional de Investigaciones Oncológicas (CNIO)) The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are foc...

Charities unite to award $2.5 million for breast and prostate cancer research

(University of Adelaide) Leading Australian cancer researcher Professor Wayne Tilley has today been presented with a $2.5 million Breast & Prostate Cancer Linkage Grant, thanks to a groundbreaking col...

Similarities between next-generation prostate cancer drugs discovered

For the first time, researchers have shown how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized....

Team discovers similarities between next-generation prostate cancer drugs

Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they ...

Prostate Cancer Pipeline H1 2017 Therapeutic Key Players 3-V Biosciences Inc, 4SC AG, Actinium ...

Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms Read more...

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for ...

Cleveland Clinic discovers similarities between next-generation prostate cancer drugs

(Cleveland Clinic) Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change dep...

Boston Prostate Cancer Walk & 5K Run

MARLBOROUGH, Mass., Aug. 23, 2013 /PRNewswire-USNewswire/ -- The Cancer Resource Foundation hosts the 13th Annual Boston Prostate Walk & 5K to support prostate cancer in Massachusetts.  The...

Drugs and Medications [961 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [9769 Associated PubMed Articles listed on BioPortfolio]

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.

More than any other cancer, prostate cancer screening with the prostate-specific antigen (PSA) tests increases the risk a man will have to face a diagnosis of prostate cancer. The best evidence from s...

c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.

miR-493-5p downregulation has emerged as a critical player in cancer progression yet, the underlying mechanisms of miR-493-5p expression pattern and its function in prostate cancer remains to be eluci...

Histopathology of Prostate Cancer.

This review focuses on histopathological aspects of carcinoma of the prostate. A tissue diagnosis of adenocarcinoma is often essential for establishing a diagnosis of prostate cancer, and the foundati...

Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.

Intraductal carcinoma of the prostate (IDC-P) is a distinct histopathologic feature associated with high-grade, advanced prostate cancer. Although studies have shown that IDC-P is a predictor of progr...

Effect of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer.

Backgraoung and Objective: Prostate cancer is the most prevalent non-cutaneous cancer in men, which causes significant mortality among the patients. Since prostate cancer cells are stimulated by andro...

Clinical Trials [7624 Associated Clinical Trials listed on BioPortfolio]

Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate Cancer

This study compared a plant-based, olive oil diet to the diet recommended by the Prostate Cancer Foundation for weight loss and improvement in some laboratory biomarkers.

Randomized Study of Pre-Prostatectomy Celecoxib or Placebo

This study will seek to determine if the downstream effects of COX-2 inhibition suggested by preclinical systems occur in human prostate cancer. To answer this question, men who have chose...

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

RATIONALE: Vitamin E supplements may stop or delay the development of prostate cancer in patients who are at risk of prostate cancer or who have prostate cancer. It is not yet known which ...

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

This study is for men who have prostate cancer that has spread outside of the prostate gland and is no longer responding to hormone removal therapy. This study is designed to determine if...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Companies [2983 Associated Companies listed on BioPortfolio]

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for pro...

Prostate Cancer Foundation of Chicago

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United St...

More Information about "Prostate Cancer Foundation of Chicago" on BioPortfolio

We have published hundreds of Prostate Cancer Foundation of Chicago news stories on BioPortfolio along with dozens of Prostate Cancer Foundation of Chicago Clinical Trials and PubMed Articles about Prostate Cancer Foundation of Chicago for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prostate Cancer Foundation of Chicago Companies in our database. You can also find out about relevant Prostate Cancer Foundation of Chicago Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record